Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ADH1B | P00325 | 2/20 | 0.46 |
| ▸ | ADH1C | P00326 | 2/20 | 0.46 |
| ▸ | ADH1A | P07327 | 2/20 | 0.46 |
| ▸ | ADH4 | P08319 | 2/20 | 0.46 |
| ▸ | ADH7 | P40394 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.45 |
| ▸ | GAPDH | P04406 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10432807 | 0.97 | ADH1B (0.50) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL7104793 | 0.97 | ADH1B (0.50) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL17509727 | 0.97 | ADH1B (0.50) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9576172 | 0.97 | ADH1B (0.50) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL28582956 | 0.97 | ADH1B (0.50) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL14010386 | 0.92 | — | — | |
| SCHEMBL28172141 | 0.87 | TSHR (0.54) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL361635 | 0.85 | TSHR (0.41) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL28011570 | 0.85 | ADH1B (0.45) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL11870095 | 0.84 | ADH1B (0.44) | TSHRSMN1; SMN2ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3328427-B1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | MASSACHUSETTS GEN HOSPITAL (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20230303709-A1 | Antibody Derivatives with Conditionally Enabled Effector Function | THE GENERAL HOSPITAL CORPORATION | 2023-09-28 | — | — | US | disclosed |
| US-20180215831-A1 | Antibody Derivatives with Conditionally Enabled Effector Function | THE GENERAL HOSPITAL CORPORATION | 2018-08-02 | — | — | US | disclosed |
| EP-3344678-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2018-07-11 | — | — | EP | disclosed |
| EP-3328427-A1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | The General Hospital Corporation (US) | 2018-06-06 | — | — | EP | disclosed |
| EP-3180382-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2017-06-21 | — | — | EP | disclosed |
| EP-2046375-B1 | METHODS AND COMPOSITIONS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | MASSACHUSETTS GEN HOSPITAL (US) | 2017-04-05 | — | — | EP | disclosed |
| WO-2017037070-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2017-03-09 | — | — | WO | disclosed |
| WO-2017019729-A1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | THE GENERAL HOSPITAL CORPORATION (US) | 2017-02-02 | — | — | WO | disclosed |
| WO-2016023837-A1 | AMINE FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2016-02-18 | — | — | WO | disclosed |
| CN-101821239-A | 3-alkoxyl group-1-phenylpyrazole derivatives and noxious organism control agent | KUMIAI CHEMICAL INDUSTRY CO | 2010-09-01 | — | — | CN | disclosed |
| EP-2178559-A2 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | The General Hospital Corporation (US) | 2010-04-28 | — | — | EP | disclosed |
| US-20100055761-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORAL TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| EP-2046375-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | The General Hospital Corporation (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2009014650-A2 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | THE GENERAL HOSPITAL CORPORATION (US) | 2009-01-29 | — | — | WO | disclosed |
| WO-2008011157-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2008-01-24 | — | — | WO | disclosed |
| EP-0306521-B1 | ETHINE DERIVATIVES AS COMPOUNDS OF LIQUID CRYSTAL PHASES | MERCK PATENT GmbH (DE) | 1991-10-16 | — | — | EP | disclosed |
| EP-0351641-A1 | 1-Phenylpyrrole | NIHON BAYER AGROCHEM K.K. (JP) | 1990-01-24 | — | — | EP | disclosed |
| EP-0306521-A1 | ETHINE DERIVATIVES AS COMPOUNDS OF LIQUID CRYSTAL PHASES. | MERCK PATENT GMBH (DE) | 1989-03-15 | — | — | EP | disclosed |
| WO-1988007516-A1 | ETHINE DERIVATIVES AS COMPOUNDS OF LIQUID CRYSTAL PHASES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | disclosed |